Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Conatus Announces Top-Line Results From ACLF and Organ Impairment Clinical Trials of Emricasan

GlobeNewswire January 8, 2015

Conatus Announces Top-Line Results From ACLF and Organ Impairment Clinical Trials of Emricasan

GlobeNewswire January 8, 2015

Verastem Provides Year-End 2014 Update and Outlook for 2015

Business Wire January 8, 2015

Cerulean Secures Debt Facility from Hercules Technology Growth Capital of Up to $26.0 Million

Business Wire January 8, 2015

QIAGEN Exceeds 2014 Goal to Achieve 1,250 Cumulative QIAsymphony System Placements and Expands artus U.S. Test Menu

PR Newswire January 8, 2015

New class of antibiotics - bioengineered to deter the development of antibiotic resistance

PR Newswire January 8, 2015

AMP has Strong Presence at FDA Workshop on LDTs, Delivers Message of Optimizing Patient Care through Molecular Diagnostics

Business Wire January 8, 2015

Athersys to Present at Biotech Showcase 2015

GlobeNewswire January 8, 2015

BEAT BioTherapeutics dATP Technology Improves Cardiac Function in End Stage Human Heart Failure Cardiac Muscle

Business Wire January 8, 2015

NW Bio To Present At Biotech Showcase Conference

PR Newswire January 8, 2015

17th Annual BIO CEO & Investor Conference to Feature U.S. Representatives Fred Upton and Diana DeGette

Business Wire January 8, 2015

Sterne, Kessler, Goldstein & Fox Announces Election Of Largest Director Class In Firm History

PR Newswire January 8, 2015

LifeVantage CSO Presenting at Biochemical Society Keap1/Nrf2 Pathway in Health and Disease Meeting

GlobeNewswire January 8, 2015

Sienna Labs Appoints Clint Carnell to Board of Directors

PR Newswire January 8, 2015

ATHENA data publication reinforces new interim guidance from medical societies on use of HPV as first-line test in cervical cancer screening

PR Newswire January 8, 2015

BTCS Provides Mining Update, Receives Two Digital Currency ATMs and Introduces New Logo to Reflect Universal Strategy

Marketwired January 8, 2015

Stealth BioTherapeutics Announces the Appointment of Mark P. Colonnese as Chief Financial Officer

Business Wire January 8, 2015

Tauriga Sciences Inc. Announces the Launch of Its taurigastore.com eCommerce Website

PR Newswire January 8, 2015

NCCN and Flatiron Health Announce Collaboration to Launch Novel Oncology Outcomes Database

Marketwired January 8, 2015

F1000research Is Successfully Transforming the Way Science Is Shared

Marketwired January 8, 2015